Is AOD-9604 Legal in Maryland?
HealthRX.com
AOD-9604 has no federal approval or compounding listing
From the public record
FDA product listings naming AOD-9604
The FDA NDC Directory holds 5 listings naming AOD-9604 from 5 firms: 5 bulk ingredient listings and 0 finished product listings, 0 under an FDA-approved application. A listing is a registration by a firm, not an FDA approval.
| Measure | Value | Note |
|---|---|---|
| Listings naming AOD-9604 | 5 | |
| Bulk ingredient listings | 5 | raw material registrations, not finished medicines |
| Of those, bulk ingredient for human prescription compounding | 1 | |
| Finished product listings | 0 | |
| Listings under an FDA-approved application | 0 | |
| Firms with a listing | 5 |
How this was calculated
Searched ingredient and product names in the NDC Directory download for the exact name variants, then counted listings by FDA marketing category and by listing firm.
Current NDC Directory listings whose ingredient or product name contains AOD-9604 or AOD 9604 or AOD9604
Firms submit listings themselves. A listing does not mean FDA has reviewed the substance for safety or effectiveness, or that it may lawfully be compounded.
At a glance
- FDA approval / Not approved for any use [1][2]
- FDA compounding-risk page / Listed in the 'nominated but withdrawn' table; concerns include immunogenicity, limited safety data and serious adverse events of unclear causality [3]
- State-licensed pharmacy list / In none of the three categories; the category 1 policy does not cover it [4][6]
- Outsourcing-facility list / Not listed [5]
- HHS draft peptide policy / Not one of the six named peptides [7][8]
- Sport / WADA prohibits AOD-9604 at all times [9][10]
What is AOD-9604?
AOD-9604 is a 16-amino-acid modified fragment of human growth hormone: hGH amino acids 177 to 191 with an extra tyrosine at the N-terminus, which is why it is also called hGH fragment 176-191 [11][2]. It is not full-length growth hormone. Metabolic Pharmaceuticals developed it as an anti-obesity candidate; phase IIa trials were underway by February 2002, and it never reached FDA approval [1][2].
The human efficacy record is thin. A 2026 review states that a 24-week oral study (534 enrolled, 502 randomized) failed to show a significant benefit on the primary weight-loss endpoint, and the review says that conclusion rests on sponsor-reported phase 2 results [2].
Is AOD-9604 on FDA's compounding lists?
No. FDA's list for state-licensed pharmacies and physicians has three categories; AOD-9604 appears in none of them, so the category 1 no-action policy does not apply [4][6]. FDA's list for outsourcing facilities does not include it either [5]. AOD-9604 is not one of the six peptides named in HHS's draft enforcement-discretion policy for compounding [7][8].
FDA's safety-risk page places AOD-9604 in the 'nominated but withdrawn' table, which holds substances previously in category 2 whose nominators withdrew them. FDA's stated concerns are immunogenicity risk for certain routes of administration due to peptide impurities and characterization problems, no or limited safety information, and serious adverse events that may be associated with AOD-9604, though causality is not clear. Removal from category 2 was not a finding that it is safe [3].
Does a prescription make it legal?
FDA describes a valid patient-specific prescription as one of the conditions for the state-licensed compounding exemption; a prescription alone does not make a product FDA-approved [12]. FDA also states that compounded drugs are not FDA-approved and that it does not review their safety, effectiveness or quality before they reach patients [12]. On the federal record, there is no approved AOD-9604 product, and AOD-9604 has no listed bulk-substance route for compounding.
What about the GRAS claim?
FDA's GRAS Notice Inventory contains no AOD-9604 notice, so there is no FDA 'no questions' letter for it [13]. The developer announced in 2012 a 'conditional GRAS' conclusion by a panel it commissioned, for use as a food or drink ingredient at up to 1 mg per day; that was not an FDA review and does not cover injected or compounded drug use [13]. GRAS is a food-ingredient concept, not a drug approval [14].
What does Maryland law say?
No Maryland statute or Board of Pharmacy rule specific to AOD-9604 is established here, so a Maryland yes-or-no answer cannot be given. What can be stated is the federal position: AOD-9604 is not approved and is outside FDA's compounding lists [1][2][4][5][6].
Is AOD-9604 banned in sport?
Yes. WADA's Prohibited List names AOD-9604 and hGH 176-191 in its growth-hormone-fragment section and prohibits them at all times, in and out of competition [9][10].
Check what you know
Question 1 of 5
Score: 0 right, 0 of 5 answered
Frequently asked questions
Is AOD-9604 legal in Maryland?
Is AOD-9604 FDA-approved?
Can a state-licensed pharmacy compound AOD-9604?
Did FDA declare AOD-9604 safe through GRAS?
Is AOD-9604 banned in sport?
Reader questions
What people actually ask
Short answers drawn from the sources this article cites.
What peptides are legal in the USA?
Only AOD-9604 is covered here, and on the federal record it is not a legal option: it is not FDA-approved and appears in none of FDA's compounding categories. It is also not one of the six peptides named in HHS's draft enforcement-discretion policy for compounding.
Will peptides fail a drug test?
Whether a drug test would detect AOD-9604 is not established. What is stated is that WADA's Prohibited List names AOD-9604 and hGH 176-191 and prohibits them at all times, in and out of competition.
References
Show all 14 referencesHide references
- Wilding J. AOD-9604 Metabolic. Curr Opin Investig Drugs. 2004;5(4):436-40.
- Dominikowski A, Rękoś Z, Olejarz M, Szczepanek-Parulska E, Domin R, RuchaŁa M. The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration. Front Endocrinol (Lausanne). 2026;17:1822475.
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- Bulk Drug Substances Used in Compounding of the FD&C Act | FDA.
- Official web page.
- Official web page.
- World Anti-Doping Agency.
- World Anti-Doping Agency.
- Cox HD, Smeal SJ, Hughes CM, Cox JE, Eichner D. Detection and in vitro metabolism of AOD9604. Drug Test Anal. 2015;7(1):31-8.
- Human Drug Compounding Laws | FDA.
- GRAS Notices.
- Generally Recognized as Safe (GRAS) | FDA.